Viewing Study NCT00257192


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2026-01-11 @ 3:36 AM
Study NCT ID: NCT00257192
Status: TERMINATED
Last Update Posted: 2021-03-25
First Post: 2005-11-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A1281134
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators